Skip to main content

4-Deep Brain Reconstruction

Objective

The 4-Deep Brain Reconstruction, 4-DBR consortium aims at generating a brand-new technological approach to regenerate brain affections that occurs in neurological disorders. With 180 million affected people and an economic burden of 798 billion euros/year, Europe needs a radical leap in the future. The complexity of the human brain has condemned every past attempt at regeneration because incomplete technologies did not allow for a full recapitulation of the brain properties and any one of them missing jeopardized the functionality of the whole. There can't be any incremental solution for brain damage, the technology must be all-in. 4-DBR will focus on developing an implantable 4D reconstructed brain able to recapitulate all brain properties: a complex architecture of neuronal cells integrated in a complete blood circuitry, that will be complemented with an integrated opto-stimulator to induce correct specification and integration of neurons. 4-DBR integrates 6 technological leaders from complementary fields who will unite to develop the components of reconstructed-brains: laser-assisted bioprinting of pre-differentiated neurons with their native decellularized brain matrix, extrusion bioprinting of vascular system, in vitro blood-brain-barrier reconstruction and a tissue integrated wireless-controlled stimulating optoelectrical chip. These 4 components will then be combined into a transplantable reconstructed brain that will be tested in a small animal model of Huntington’s disease. While a first prototype will be delivered in 36 months, the vision unifying 4-DBR expands way further. Therefore, the project will put into action a strong dissemination and exploitation plan: horizontally, 4-DBR will ensure the uptake of the generated methods to strengthen Europe’s technological actors; vertically, 4-DBR will thrust the reconstructed brain approach up in the development ladder to potentially generate in a 10-year span a therapy to change the lives of many patients.

Coordinator

CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
Net EU contribution
€ 729 500,00
Address
Calle Rossello 149 Puerta Bjs
08036 Barcelona
Spain

See on map

Region
Este Cataluña Barcelona
Activity type
Other
Other funding
€ 0,00

Participants (5)

POIETIS
France
Net EU contribution
€ 510 028,75
Address
27 Alle Charles Darwin
33600 Pessac

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Nouvelle-Aquitaine Aquitaine Gironde
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00
VERIGRAFT AB
Sweden
Net EU contribution
€ 489 212,50
Address
Arvid Wallgrens Backe 20
413 46 Goteborg

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Södra Sverige Västsverige Västra Götalands län
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00
DANMARKS TEKNISKE UNIVERSITET
Denmark
Net EU contribution
€ 429 983,75
Address
Anker Engelundsvej 1 Bygning 101 A
2800 Kgs Lyngby

See on map

Region
Danmark Hovedstaden Københavns omegn
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00
OSPEDALE SAN RAFFAELE SRL
Italy
Net EU contribution
€ 510 000,00
Address
Via Olgettina 60
20132 Milano

See on map

Region
Nord-Ovest Lombardia Milano
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00
UNIVERSITAT DE BARCELONA
Spain
Net EU contribution
€ 319 050,00
Address
Gran Via De Les Corts Catalanes 585
08007 Barcelona

See on map

Region
Este Cataluña Barcelona
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00